Septerna (SEPN) Depreciation & Amortization (CF) (2023 - 2026)
Septerna (SEPN) recorded quarterly Depreciation & Amortization (CF) of $421000.0 in Q1 2026, up 4.99% quarter-over-quarter from $401000.0 in Q4 2025, and up 6.05% on a YoY basis from $397000.0 in Q1 2025.
Septerna (SEPN) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Septerna's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $421000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 6.05% year-over-year to $421000.0; the TTM figure through Mar 2026 stood at $1.6 million (up 9.85% YoY), while the FY2025 annual figure was $1.6 million, up 14.49% from the prior year.
- Depreciation & Amortization (CF) was $421000.0 for Q1 2026 at Septerna, up from $401000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $421000.0 in Q1 2026 to a low of $243000.0 in Q4 2023.
- Historically, Depreciation & Amortization (CF) has averaged $366900.0 across 4 years, with a median of $392500.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) jumped 59.67% in 2024, then climbed 3.35% in 2025.
- A 4-year view of Depreciation & Amortization (CF) shows it stood at $243000.0 in 2023, then jumped by 59.67% to $388000.0 in 2024, then advanced by 3.35% to $401000.0 in 2025, then rose by 4.99% to $421000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $421000.0 (Q1 2026), $401000.0 (Q4 2025), and $401000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 421,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 421,000.00 |
| Mar 31, 2026 | 421,000.00 |
| Dec 31, 2025 | 401,000.00 |
| Dec 31, 2025 | 401,000.00 |
| Sep 30, 2025 | 401,000.00 |
| Sep 30, 2025 | 401,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Mar 31, 2025 | 397,000.00 |
| Mar 31, 2025 | 397,000.00 |
| Dec 31, 2024 | 388,000.00 |
| Dec 31, 2024 | 388,000.00 |
| Sep 30, 2024 | 364,000.00 |
| Sep 30, 2024 | 364,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Mar 31, 2024 | 316,000.00 |
| Mar 31, 2024 | 316,000.00 |
| Dec 31, 2023 | 243,000.00 |
| Dec 31, 2023 | 243,000.00 |